Weighted Average Number of Shares Outstanding, Basic of Nabriva Therapeutics plc from 2014 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Nabriva Therapeutics plc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and change rate from 2014 to Q2 2023.
  • Nabriva Therapeutics plc Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2023 was 3.23M shares, a 27.7% increase year-over-year.
  • Nabriva Therapeutics plc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 2.68M shares, a 54.7% increase from 2021.
  • Nabriva Therapeutics plc annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 1.73M shares, a 237% increase from 2020.
  • Nabriva Therapeutics plc annual Weighted Average Number of Shares Outstanding, Basic for 2020 was 514K shares, a 93.1% decline from 2019.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Nabriva Therapeutics plc Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 3.23M +701K +27.7% Apr 1, 2023 Jun 30, 2023 10-Q 2023-10-19
Q1 2023 3.2M +850K +36.1% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-22
Q4 2022 2.68M +948K +54.7% Oct 1, 2022 Dec 31, 2022 10-K 2023-04-17
Q3 2022 2.73M +712K +35.2% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 2.53M -38M -93.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-10-19
Q1 2022 2.35M -24.1M -91.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q4 2021 1.73M Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 2.02M -12.4M -86% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 40.6M +29.3M +260% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 26.4M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q3 2020 14.5M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 11.3M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q2 2017 27.2M +5.93M +27.9% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-07
Q1 2017 2.72M +603K +28.4% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-10
Q2 2016 21.3M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 2.12M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10

Nabriva Therapeutics plc Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 2.68M +948K +54.7% Jan 1, 2022 Dec 31, 2022 10-K 2023-04-17
2021 1.73M +1.22M +237% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-17
2020 514K -6.91M -93.1% Jan 1, 2020 Dec 31, 2020 10-K 2023-04-17
2019 7.42M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-29
2016 2.15M +1.09M +103% Jan 1, 2016 Dec 31, 2016 10-K 2017-03-24
2015 1.06M +734K +226% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-24
2014 325K Jan 1, 2014 Dec 31, 2014 10-K 2017-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.